Antidiabetic activity, alpha-amylase, and alpha-glucosidase inhibitory effect of Tradescantia spathacea Swartz extract

Nagaraju Jesetti (1) , Rajasekhar Reddy Alavala (2) , Subhakar Raju Rapaka (3) , Umasankar Kulandaivelu (4) , Koteswara Rao GSN (5)
(1) Research scholar, K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur, Andhra Pradesh-522502, India / Department of Pharmacology, Balaji Institute of Pharmaceutical Sciences, Laknepally, Narsampet, Warangal, Telangana-506331, India, India ,
(2) Department of Pharmacy, K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur, Andhra Pradesh-522 502, India, India ,
(3) Department of Pharmacy, K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur, Andhra Pradesh-522 502, India, India ,
(4) Department of Pharmacy, K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur, Andhra Pradesh-522 502, India, India ,
(5) Department of Pharmacy, K L College of Pharmacy, Koneru Lakshmaiah Education Foundation, Vaddeswaram, Guntur, Andhra Pradesh-522 502, India, India

Abstract

Tradescantia spathacea Swartz belongs to the genus Commelinaceae, a tropical tree used in many countries as an herbal drug for the care of diabetic patients. The aim of this study was to examine anti-diabetic activity of the Tradescantia spathacea Swartz methanolic extract (METSW) and the in-vitro activity of α-amylase, and α-glucosidase was carried out. METSW compared with acarbose inhibition of the α-amylase and α-glucosidase enzyme, METSW exhibited IC50 less than 100µg/mL would be considered as healthy. The METSW showed IC50 66.22 ± 0.52µg/mL α-amylase activity, acarbose revealed an IC50  of 83.25 ± 1.28µg/mL. METSW demonstrated IC50  levels   of 85.37 ± 0.72 µg/mL (y= 0.095x+41.89) inhibition of the α-Glucosidase enzymes. METSW at 400 mg/kg greatly decreased the region under the blood glucose level curve in a typical rat test for oral glucose tolerance. The single dose of the extract decreased dramatically from 211 mg/dl to 89.22 mg/dl at 400 mg/kg METSW in the alloxan induced diabetic model. METSW possesses strong antidiabetic activity in vivo and in vitro. Besides, the extract has also been shown to have a significant inhibitory activity of α-amylase and α- glucosidase which may lead to its anti-hyperglycemic function when used in diabetic patients.

Full text article

Generated from XML file

Authors

Nagaraju Jesetti
nagarajupharma@gmail.com (Primary Contact)
Rajasekhar Reddy Alavala
Subhakar Raju Rapaka
Umasankar Kulandaivelu
Koteswara Rao GSN
Nagaraju Jesetti, Rajasekhar Reddy Alavala, Subhakar Raju Rapaka, Umasankar Kulandaivelu, & Koteswara Rao GSN. (2020). Antidiabetic activity, alpha-amylase, and alpha-glucosidase inhibitory effect of Tradescantia spathacea Swartz extract. International Journal of Research in Pharmaceutical Sciences, 11((SPL 4), 1594–1599. Retrieved from https://ijrps.com/home/article/view/2239

Article Details

No Related Submission Found